ABBV stock · PLUS stock

ABBV vs PLUS

AbbVie Inc (ABBV) versus ePlus inc (PLUS) — a side-by-side from cached financials, not a winner call.

AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.

ePlus inc (PLUS) is a software - application company listed on NASDAQ.

Latest reported ABBV revenue for 2025-12-31 was $61.16B. Net income was $4.23B. Revenue was up 305.0% from 2024-12-31 to 2025-12-31. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.

Latest reported PLUS revenue for 2025-03-31 was $2.07B. Net income was $108.0M. Revenue was down 7.0% from 2024-03-31 to 2025-03-31. PLUS currently screens at market cap $2.10B and trailing P/E 17.1.

ABBV currently screens at market cap $334.34B and trailing P/E 80.5. PLUS currently screens at market cap $2.10B and trailing P/E 17.1.

Not investment advice. Open the ABBV and PLUS stock pages for the full models.

Not investment advice.

Popular Stock Comparisons